An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway
Pharmaceutical Research · 2024
DOI: 10.1007/s11095-024-03790-3 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutical Research, 2024. Verfasst von Huiying Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 511436, Guangdong, P. R. China. Hauptthemen laut MEDLINE: Administration, Intranasal, Drug Delivery Systems, Blood-Brain Barrier, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 116 Literaturangaben. Gefördert von: the National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province of China, Project of Administration of Traditional Chinese Medicine of Guangdong Province of China.
Abstract (Originalsprache)
OBJECTIVE: To explore the potential of transnasal drug delivery systems (DDS) as an effective means of bypassing the bloodbrain barrier (BBB) for enhanced central nervous system (CNS) targeting, aiming to improve therapeutic outcomes for CNS disorders while reducing systemic side effects. METHODS: A review of current and emerging DDS technologies, including polymer nanoparticles, liposomes, and micelles, was conducted to assess their suitability for precision-targeted delivery to the brain through the transnasal route. RESULTS: The investigated DDS demonstrate promising capabilities for CNS targeting via the nasal pathway, effectively preserving both the nasal mucosa and CNS integrity. These systems enhance drug precision within neural tissues, potentially improving therapeutic outcomes without harming adjacent tissues. CONCLUSIONS: Transnasal DDS offer a promising alternative to traditional delivery methods, with significant potential to advance the treatment of cerebrovascular diseases, neurodegenerative disorders, brain tumors, and psychiatric conditions. This approach represents an evolving frontier in neurotherapeutics, with the potential to transform CNS drug delivery practices.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 511436, Guangdong, P. R. China.
- College of Pharmacy, Jinan University, Guangzhou, 511436, Guangdong, P. R. China.
- State Key Laboratory of Bioactive Molecules and Druggability Assessment, Jinan University, Guangzhou, 511436, Guangdong, P. R. China. inzahu@hotmail.com.
- College of Pharmacy, Jinan University, Guangzhou, 511436, Guangdong, P. R. China. inzahu@hotmail.com.
Förderung
- the National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province of China
- Project of Administration of Traditional Chinese Medicine of Guangdong Province of China
Zitieren
APA
Zeng, H., Lu, H., Yang, J., & Hu, P. (2024). An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway. Pharmaceutical Research. https://doi.org/10.1007/s11095-024-03790-3
Vancouver
Zeng H, Lu H, Yang J, Hu P. An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway. Pharmaceutical Research. 2024. doi:10.1007/s11095-024-03790-3
BibTeX
@article{Zeng2024,
author = {Zeng, Huiying and Lu, Huangjie and Yang, Jie and Hu, Ping},
title = {An Update on Recent Drug Delivery Systems Targeting Brain Diseases via the Transnasal Pathway},
journal = {Pharmaceutical Research},
year = {2024},
doi = {10.1007/s11095-024-03790-3}
}
EUVIMED